ES8405778A1 - Procedimiento para la preparacion de nuevos benzo-heterociclos. - Google Patents

Procedimiento para la preparacion de nuevos benzo-heterociclos.

Info

Publication number
ES8405778A1
ES8405778A1 ES521871A ES521871A ES8405778A1 ES 8405778 A1 ES8405778 A1 ES 8405778A1 ES 521871 A ES521871 A ES 521871A ES 521871 A ES521871 A ES 521871A ES 8405778 A1 ES8405778 A1 ES 8405778A1
Authority
ES
Spain
Prior art keywords
hydrogen
preparation
heterociclos
procedure
broncolitics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521871A
Other languages
English (en)
Other versions
ES521871A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Publication of ES8405778A1 publication Critical patent/ES8405778A1/es
Publication of ES521871A0 publication Critical patent/ES521871A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE BENZO-HETEROCICLOS, DE FORMULA GENERAL (I), EN LA QUE A SIGNIFICA UN ENLACE SIMPLE O EL GRUPO -CH2-CH2-; R1 SIGNIFICA OH, O-ACILO, CLORO O HIDROGENO; R2 SIGNIFICA HIDROGENO, METILO O ETILO; Y R3 SIGNIFICA UN RADICAL, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HIDROGENAR UN COMPUESTO DE FORMULA (II), EN LA QUE A Y R2 TIENEN LOS SIGNIFICADOS YA INDICADOS; R1 SIGNIFICA UN GRUPO BENCILOXI; R3 REPRESENTA R3; Y R REPRESENTA HIDROGENO O BENCILO EVENTUALMENTE SUSTITUIDO. LA REACCION DE HIDROGENACION SE EFECTUA EN UN DISOLVENTEA TEMPERATURA AMBIENTE Y EN PRESENCIA DE UN CATALIZADOR DE HIDROGENACION, HASTA LA ABSORCION DE LA CANTIDAD CALCULADA DE HIDROGENO.DE APLICACION EN LA PREPARACION DE MEDICAMENTOS POR SUS EFECTOS BRONCOLITICOS, ESPASMOLITICOS Y ANTIALERGICOS.
ES521871A 1981-09-01 1983-04-27 Procedimiento para la preparacion de nuevos benzo-heterociclos. Granted ES521871A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813134590 DE3134590A1 (de) 1981-09-01 1981-09-01 Neue benzo-heterocyclen

Publications (2)

Publication Number Publication Date
ES8405778A1 true ES8405778A1 (es) 1984-06-16
ES521871A0 ES521871A0 (es) 1984-06-16

Family

ID=6140603

Family Applications (3)

Application Number Title Priority Date Filing Date
ES515380A Granted ES515380A0 (es) 1981-09-01 1982-08-31 "procedimiento para la preparacion de nuevos benzo-heterociclos".
ES521870A Granted ES521870A0 (es) 1981-09-01 1983-04-27 Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES521871A Granted ES521871A0 (es) 1981-09-01 1983-04-27 Procedimiento para la preparacion de nuevos benzo-heterociclos.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES515380A Granted ES515380A0 (es) 1981-09-01 1982-08-31 "procedimiento para la preparacion de nuevos benzo-heterociclos".
ES521870A Granted ES521870A0 (es) 1981-09-01 1983-04-27 Procedimiento para la preparacion de nuevos benzo-heterociclos.

Country Status (25)

Country Link
EP (1) EP0073505B1 (es)
JP (1) JPS5852278A (es)
KR (1) KR890000380B1 (es)
AR (2) AR231976A1 (es)
AT (1) ATE16703T1 (es)
AU (1) AU553589B2 (es)
CA (1) CA1180012A (es)
CS (1) CS236679B2 (es)
DD (1) DD204477A5 (es)
DE (2) DE3134590A1 (es)
DK (1) DK158664C (es)
ES (3) ES515380A0 (es)
FI (1) FI78475C (es)
GB (1) GB2106105B (es)
GR (1) GR77275B (es)
HU (1) HU186112B (es)
IE (1) IE53615B1 (es)
IL (1) IL66683A0 (es)
NO (1) NO157738C (es)
NZ (1) NZ201777A (es)
PL (1) PL139375B1 (es)
PT (1) PT75478A (es)
SU (1) SU1149876A3 (es)
YU (1) YU42794B (es)
ZA (1) ZA826349B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
DE3743265A1 (de) * 1987-12-19 1989-06-29 Boehringer Ingelheim Kg Neue ammoniumverbindungen, ihre herstellung und verwendung
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
USD474664S1 (en) 2002-04-30 2003-05-20 Trudeau Corporation 1889 Inc. Corkscrew
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
AU2004226824B2 (en) * 2003-04-04 2008-05-01 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
GB0307856D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
US7307076B2 (en) 2004-05-13 2007-12-11 Boehringer Ingelheim International Gmbh Beta agonists for the treatment of respiratory diseases
EP1789394A1 (de) * 2004-05-13 2007-05-30 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
KR101360803B1 (ko) * 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2057152A1 (de) * 2006-08-07 2009-05-13 Boehringer Ingelheim International GmbH Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
NZ579007A (en) * 2007-01-25 2012-02-24 Boehringer Ingelheim Int Method for producing betamimetics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035749A1 (es) * 1969-02-06 1970-12-24 Bellon Labor Sa Roger
DE2429253A1 (de) * 1974-06-19 1976-01-15 Boehringer Sohn Ingelheim Phenylalkanolamine

Also Published As

Publication number Publication date
NO157738B (no) 1988-02-01
DK158664B (da) 1990-07-02
YU42794B (en) 1988-12-31
GR77275B (es) 1984-09-11
NO157738C (no) 1988-05-11
NO822932L (no) 1983-03-02
PT75478A (en) 1982-09-01
JPH035392B2 (es) 1991-01-25
EP0073505A1 (de) 1983-03-09
ES8402279A1 (es) 1984-01-16
FI822985L (fi) 1983-03-02
DK389082A (da) 1983-03-02
ES521870A0 (es) 1984-01-16
DE3267702D1 (en) 1986-01-09
SU1149876A3 (en) 1985-04-07
HU186112B (en) 1985-06-28
PL238077A1 (en) 1984-04-09
IL66683A0 (en) 1982-12-31
EP0073505B1 (de) 1985-11-27
AU8787482A (en) 1983-03-10
KR840001560A (ko) 1984-05-07
JPS5852278A (ja) 1983-03-28
KR890000380B1 (ko) 1989-03-15
FI78475B (fi) 1989-04-28
GB2106105A (en) 1983-04-07
AU553589B2 (en) 1986-07-24
IE53615B1 (en) 1988-12-21
FI822985A0 (fi) 1982-08-30
ES8308318A1 (es) 1983-08-16
PL139375B1 (en) 1987-01-31
DE3134590A1 (de) 1983-03-10
ZA826349B (en) 1984-04-25
YU194982A (en) 1984-12-31
ES521871A0 (es) 1984-06-16
ATE16703T1 (de) 1985-12-15
IE822105L (en) 1983-03-01
CS236679B2 (en) 1985-05-15
FI78475C (fi) 1989-08-10
DK158664C (da) 1991-01-14
ES515380A0 (es) 1983-08-16
AR231977A1 (es) 1985-04-30
NZ201777A (en) 1985-08-30
AR231976A1 (es) 1985-04-30
GB2106105B (en) 1985-07-10
CA1180012A (en) 1984-12-27
DD204477A5 (de) 1983-11-30

Similar Documents

Publication Publication Date Title
ES8404355A1 (es) "procedimiento para preparar 9-(1,3-dihidroxi-2-propoximetil)-guanina y sus sales farmaceuticamente aceptables".
ES8604226A1 (es) Procedimiento para preparar (2-oxo-1, 2, 3, 5-tetrahidroimidazo (2, 1-b) quinazolinil) oxialquilamidas
MX9203239A (es) Derivados de 1-(dihidroxifenil)-2-amino-etanol y composiciones farmaceuticas que los contienen.
ES8604545A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES8500727A1 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES8308318A1 (es) "procedimiento para la preparacion de nuevos benzo-heterociclos".
ES8306375A1 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES2069281T3 (es) Derivado de fenantreno.
ES8607299A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
ES8605513A1 (es) Un procedimiento para preparar derivados de piridina
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ES8301200A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8101048A1 (es) Procedimiento para la preparacion de nuevos derivados indo- licos
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES8603810A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
ES8405758A1 (es) Procedimiento oxidativo del cabello.
ES463971A1 (es) Perfeccionamientos en o relacionados con compuestos organi- cos.
ES8302626A1 (es) "procedimiento de preparacion de derivados carboxilato".
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
ES8504189A1 (es) Un compuesto de pirazol (3,4-b) piridina.
ES8402280A1 (es) Procedimiento para la obtencion de benzofuranonas.
ES8603834A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
ES8405013A1 (es) Procedimiento para preparar derivados de tieno-tiazol
ES8707496A1 (es) Un procedimiento para preparar derivados de azetidinona
ES8304978A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203